Blood Platelet Disorders  >>  Soliris (eculizumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
STEC-HUS, NCT01410916 / 2011-002691-17: Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome

Completed
2/3
198
Europe
Eculizumab (Soliris®)
Alexion Pharmaceuticals
Shiga-like Toxin-producing Escherichia Coli
01/12
06/12

Download Options